Allergios
PrivateLast Round
Grant
Oct 10, 2024
Company Overview
Allergios is a medical technology company that develops an AI-powered microfluidic platform for functional allergy diagnostics, aiming to replace traditional oral provocation tests.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Allergios Comparables
Compare Allergios with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Bioherent | 81% | |
| BÜHLMANN Laboratories AG | 72% | |
| Thermo Fisher Scientific Inc. | 72% | |
Allergios Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 10, 2024 | ||||
| Seed | May 23, 2022 |
Allergios Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NLC Health Ventures | Seed |
| Health~Holland | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2022
NLC Health Ventures participated in the Seed round.
Allergios Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Allergios's valuation, stock price, and market status.